High ferritin levels, abnormal PET/CT CNS metabolism, and peripheral immunophenotype (PD-1+, TEM, CD57+, and CD73+) are some highlights that could help to recognize DM patients who are prone to developing encephalopathy symptoms. The gene discussed is B3GAT1; the disease is Encephalopathy.